𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis

✍ Scribed by Joan M. Salmerón; Luis Ruiz Del Arbol; Angels Ginès; Joan C. García-Pagán; Pere Ginés; Faust Feu; Joan Claria; Francisca Rivera; Jaume Bosch; Vicente Arroyo; Joan Rodés

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
754 KB
Volume
17
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Propranolol plus isosorbide-5-mononitrat
Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: Long-term hemodynamic and renal effects
✍ Rosa Maria Morillas; Ramon Planas; Eduard Cabré; Amparo Galán; Juan Carlos Quer; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

The effect on kidney function, vasoactive systems and ascites outcome of long-term treatment with propranolol plus isosorbide-5-mononitrate, a combined therapy proven more effective than propranolol alone in decreasing portal pressure in the cirrhotic patient, is unknown. Thirty cirrhotic patients w

Lack of effects of isosorbide-5-mononitr
Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis
✍ Yang-Te Tsai; Fa-Yauh Lee; Han-Chieh Lin; Ting-Tsung Chang; Chii-Shyan Lay; Sun- 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 543 KB

We conducted a randomized controlled hemodynamic study to evaluate the effect of placebo and 20 mg isosorbide-5-mononitrate, a long-acting organic nitrate, in 19 patients with HBsAg-positive cirrhosis by the simultaneous measurement of portal venous pressure and wedged hepatic venous pressure. Basel

Long-term administration of isosorbide-5
Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients
✍ F Salerno; G Borroni; E Lorenzano; D Solenghi; M Cazzaniga; F Bissoli; R Ceriani 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

duce hypotension and sodium retention in patients with Isosorbide-5-mononitrate (Is-5-Mn), alone or comascites. (HEPATOLOGY 1996;23:1135-1140.) bined with b-blockers, has been proposed for prophylaxis of variceal bleeding in cirrhosis. However, renal insufficiency, might be an important undesirable

Long-term effect of nadolol or nadolol p
Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis
✍ Prof. Carlo Merkel; Angelo Gatta; Carlo Donada; Edda Enzo; Renato Marin; Piero A 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 675 KB

The association beta-blockers plus nitrates has been reported to impair renal function and renal sodium handling, leading to increased risk of development of ascites, or worsening of a preexisting ascites, or increase in the requirements of diuretic agents. In 81 patients with cirrhosis and esophage

Enhancement of portal pressure reduction
Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis
✍ Joan Carles Garcia-Pagan; Miquel Navasa; Jaime Bosch; Conxita Bru; Pilar Pizcuet 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 879 KB

This study investigated whether oral doses of isosorbide-5-mononitrate, a preferential venous dilator that decreases portal pressure, could enhance the effects of propranolol on portal hypertension. Taking part in the study were 28 patients with cirrhosis and portal hypertension. Twenty patients (gr

Acute effect of ibopamine and isosorbide
Acute effect of ibopamine and isosorbide mononitrate on blood volume distribution in congestive heart failure
✍ N. D. Holman; A. B. J. Groeneveld; A. J. Schneider; J. van der Meer; O. S. Hoeks 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 546 KB

In order to compare ibopamine (IBO), a dopamine congener, with isosorbide mononitrate (ISMN) and to study their interaction in effects on the capacitance vasculature in congestive heart failure (CHF), a prospective, randomized, placebo-controlled, doubleblind clinical trial was performed in 32 patie